Patient Characteristics at Diagnosis According to the Three Groups
| Characteristics . | Total Group No. . | CD34+ Cell Dose Reinfused (×106/kg) . | ||
|---|---|---|---|---|
| ≤2.5 . | >2.5 and <15 . | ≥15 . | ||
| No. of patients | 153 | 20 | 94 | 39 |
| No. of men/women | 97/56 | 9/11 | 64/30 | 24/15 |
| Median age (yr) | 49 | 50 | 50 | 47 |
| Range | 15-66 | 24-65 | 15-66 | 24-65 |
| Histology | ||||
| NHL | 113 | 15 | 68 | 30 |
| HD | 16 | 1 | 12 | 3 |
| MM | 24 | 4 | 14 | 6 |
| No. of patients with 2 PBPC transplants | 15 | |||
| NHL | 7 | 1 | 5 | 1 |
| HD | 3 | — | 3 | — |
| MM | 5 | 1 | 3 | 1 |
| Total no. of PBPC transplants | 168 | 22 | 105 | 41 |
| Characteristics . | Total Group No. . | CD34+ Cell Dose Reinfused (×106/kg) . | ||
|---|---|---|---|---|
| ≤2.5 . | >2.5 and <15 . | ≥15 . | ||
| No. of patients | 153 | 20 | 94 | 39 |
| No. of men/women | 97/56 | 9/11 | 64/30 | 24/15 |
| Median age (yr) | 49 | 50 | 50 | 47 |
| Range | 15-66 | 24-65 | 15-66 | 24-65 |
| Histology | ||||
| NHL | 113 | 15 | 68 | 30 |
| HD | 16 | 1 | 12 | 3 |
| MM | 24 | 4 | 14 | 6 |
| No. of patients with 2 PBPC transplants | 15 | |||
| NHL | 7 | 1 | 5 | 1 |
| HD | 3 | — | 3 | — |
| MM | 5 | 1 | 3 | 1 |
| Total no. of PBPC transplants | 168 | 22 | 105 | 41 |
Abbreviations: NHL, non-Hodgkin's lymphoma; HD, Hodgkin's disease; MM, multiple myeloma; PBPC, peripheral blood progenitor cell.